A practical reference on LC-MS/MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-14 and is reviewed periodically as new material appears.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, dark | Protect from repeated temperature changes. |
| Common analytical method | LC-MS or HPLC-UV | Reference standard required for comparison. |
| Common synonyms | SR9009; Stenabolic; REV-ERB agonist | Vendor naming may vary. |
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
{\displaystyle {\begin{array}{l}{}\\{\ce {2AmF3{}+3Ba->[{\ce {1150-1350^{\circ }C}}]3BaF2{}+2Am}}\\{\ce {PuF4{}+2Ba->[{\ce {1200^{\circ }C}}]2BaF2{}+Pu}}\\{\ce {UF4{}+2Mg->[{\ce {>500^{\circ }C}}]U{}+2MgF2}}\\{}\end{array}}}
Empagliflozin/metformin, sold under the brand name Synjardy among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It contains empagliflozin and metformin hydrochloride. It is taken by mouth. The most common side effects include hypoglycaemia (low blood sugar levels) when the medicine is taken with a sulphonylurea or insulin, infections of the urinary tract and genitals, and increased urination. It was approved for use in the European Union in May 2015, for use in the United States in August 2015, and for use in Australia in May 2020. In 2020, it was the 238th most commonly prescribed medication in the United States, with more than 1 million prescriptions. It is available as a generic medication.
D-amino acid oxidase activator (DAOA, also known as G72) is a protein enriched in various parts of brain, spinal cord, and testis. DAOA is thought to interact with D-amino acid oxidase, a peroxisomal enzyme, and its gene was associated with schizophrenia in a number of studies. In separate studies it has been shown to confer susceptibility to bipolar disorder. Therefore, it has been important in researching whether the Kraepelinian dichotomy is genuine. The gene itself was discovered during an investigation of chromosomal 13q22-q34 region, which was previously linked to schizophrenia. G72 is transcribed into several proteins due to alternative splicing; the longest protein is called LG72 and consists of 153 amino acids. Although the protein was initially found to interact with DAO in yeast 2-hybrid experiment, one recent in vivo experiment showed LG72 presence only in mitochondria and failed to confirm the interaction.
doi:10.1021/acs.jproteome.5b00827. ISSN 1535-3893. PMC 5706558. PMID 26435392. Omenn, Gilbert S.; Lane, Lydie; Lundberg, Emma K.; Beavis, Ronald C.; Nesvizhskii, Alexey I.; Deutsch, Eric W. (2015). "Metrics for the Human Proteome Project 2015: Progress on the Human Proteome and Guidelines for High-Confidence Protein Identification". Journal of Proteome Research. 14 (9): 3452–3460. doi:10.1021/acs.jproteome.5b00499. ISSN 1535-3893. PMC 4755311. PMID 26155816. Fenyö, David; Beavis, Ronald C. (2015). "The GPMDB REST interface". Bioinformatics. 31 (12): 2056–2058. doi:10.1093/bioinformatics/btv107. ISSN 1367-4803. PMID 25697819.
Sources: en.wikipedia.org
Clark University 1909 Fordham University 1912 Harvard University 1936 University of Allahabad 1937 University of Benares 1937 University of Calcutta 1938 University of Oxford 1938 University of Geneva 1945 Swiss Federal Institute of Technology in Zurich 1955 on his 80th birthday In addition, he was:
== Posthumous recognition == In 1959 she became the first woman elected to the Poultry Historical Society Hall of Fame. She was inducted into the National Women's Hall of Fame in 2002, the American Society of Heating, Refrigerating and Air-Conditioning Engineers Hall of Fame in 2007, and the National Inventors Hall of Fame in 2018.
== M == Maize – first cultivated in present-day Mexico several thousand years ago, corn is currently the most cultivated grain in the world with the US being the largest cultivator of maize followed by mainland China. Over 700 million tons of maize are grown worldwide annually today in order to feed people and animals. In addition, ethanol extracted from corn is also used to fuel engines in millions of vehicles, thousands of planes, and other engines throughout the world. Manioc – Native Americans were the first peoples in the world to cultivate manioc. Maple syrup and maple sugar – indigenous Americans were the first to extract the sap from maple trees and convert the sap into maple syrup and maple sugar. Martial arts - several Native American groups have developed styles of martial arts, such as the Mapuche style of Kollellaulliñ. Mathematics – the Olmec and the Maya–who succeeded the Olmec–independently developed the concept of zero (independent of the ancient Hindus in India) in mathematics. The ancient Mexicans also developed complex arithmetic functions and operations such as additions, subtractions, divisions, and multiplications. The development of mathematics by the Mexicans assisted them in making sense of the universe, cosmos, astronomy, architecture, and pre-Columbian calendars that were so essential in maintaining a connection between them and the gods and heavens. Metallurgy in pre-Columbian America – many pre-Columbian cultures, especially the Moche in the Andean regions were skilled metallurgists.
Sources: en.wikipedia.org
Hemoglobin is a protein that transports oxygen in the blood. Genetic differences lead to structural variants in the hemoglobin protein structure. Some variants can cause disease while others have little to no effect. The normal hemoglobin types are Hemoglobin A (HbA), which makes up 95–98% of total hemoglobin in adults, Hemoglobin A2 (HbA2), which constitutes 2–3% of total hemoglobin in adults, and Hemoglobin F (HbF), which is the predominant hemoglobin in the fetus during pregnancy, and may persist in small amounts in adults. Hemoglobin variants occur when there are mutations in specific genes that code for the protein chains, known as globins, which make up the hemoglobin molecule. This leads to amino acid substitutions in the hemoglobin molecule that could affect the structure, properties, and/or the stability of the hemoglobin molecule. There are over 1,000 known mutations in the genes coding for hemoglobin in humans.
2003 saw Helton involved in the closest NL batting race in history, as he hit .35849, while St. Louis Cardinals first baseman Albert Pujols edged him out by posting a .35871 batting average to win the batting crown. Helton also had 33 home runs, 117 RBI, 135 runs, 49 doubles and five triples. He won his fourth Player of the Month honor for April, when he hit .337 with six home runs, 27 RBI, 28 runs, 11 doubles and 24 walks. He also appeared in his fourth consecutive All-Star Game. During the 2004 season, Helton again finished second in the NL batting race, as he hit .347, while San Francisco Giants left fielder Barry Bonds hit .362. Helton also had 32 home runs and 96 RBI on the season. He became the first player in MLB history to hit at least .315 with 25 home runs and 95 RBI in each of his first seven full seasons in the majors. He became only the third player in MLB history to accomplish that feat during any seven-year stretch in a career (Lou Gehrig and Babe Ruth are the others). He set a franchise record by hitting at least 30 home runs in six consecutive seasons. Helton was named to his team-record fifth consecutive All-Star Game and won his third Gold Glove during the season. In 2005, Helton was placed on the disabled list (July 26 – August 9) for the first time in his career, missing time with a strained left calf muscle. He hit .320 with 20 home runs, 79 RBI, 92 runs, and 45 doubles for the season. He was under 1.000 in OPS (finished with .979 OPS) for the first time since 1999, and was also left off the NL All-Star roster for the first time since that same year.
Furthermore, NASA gathered and published data indicating a significant heat signature at the military base, suggesting that a sizeable fire had erupted at the site overnight. In Kandahar, Pakistani officials released aerial footage of a large explosion at an ammunition depot near Kandahar International Airport (KDH). BBC News, using satellite imagery, confirmed the location of an ammunition depot in Kandahar. In Paktika, a video shared on social media showed smoke rising from a Taliban military base in the Urgun District. BBC News confirmed the location by matching roads and a distinctive foreground building with satellite imagery. Analysts at Maiar, an intelligence firm, stated that Pakistan's strikes on buildings and other infrastructure in Afghanistan appeared to be largely confined to military sites. They said that one of the buildings struck in Kabul appeared to be a military headquarters or command-and-control centre, and that vehicles parked nearby suggested the building had been occupied. In Kandahar, the analysts reported damage to at least two buildings within a large complex, which they assessed to be a headquarters of some kind. PAF airstrikes in Kandahar province also struck the former home of Mullah Omar, the late founder of the Taliban, which was currently serving as a base for the Taliban's suicide unit. The property is located about one kilometer from the residence of the current Taliban leader, Hibatullah Akhundzada. According to local Afghan sources, about 15 Taliban members were killed in the strike.
"If you lift the skin off the vagina on the side walls, you get the bulbs of the clitoris – triangular, crescental masses of erectile tissue". O'Connell et al., having performed dissections on the vulvas of cadavers and used photography to map the structure of nerves in the clitoris, made the assertion in 1998 that there is more erectile tissue associated with the clitoris than is generally described in anatomical textbooks and were thus already aware that the clitoris is more than just its glans. They concluded that some females have more extensive clitoral tissues and nerves than others, especially having observed this in young cadavers compared to elderly ones, and therefore whereas the majority of females can only achieve orgasm by direct stimulation of the external parts of the clitoris, the stimulation of the more generalized tissues of the clitoris via vaginal intercourse may be sufficient for others. French researchers Odile Buisson and Pierre Foldès reported similar findings to that of O'Connell's. In 2008, they published the first complete 3D sonography of the stimulated clitoris and republished it in 2009 with new research, demonstrating how erectile tissue of the clitoris engorges and surrounds the vagina. Based on their findings, they argued that women may be able to achieve vaginal orgasm through stimulation of the G-spot because the clitoris is pulled closely to the anterior wall of the vagina when the woman is sexually aroused and during vaginal penetration.
Sources: en.wikipedia.org
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.
The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.
Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.